What physicians need patients to understand about cannabidiol products ...

A medically formulated THC and CBD treatment reduced agitation in a blinded trial involving people with late-stage dementia.

Read more about how standardized outcome measures and design parameters impact Fragile X Syndrome clinical trials in a new ...

With the Gordie Howe International Bridge set to open on Monday, there are many questions you may have about travelling across it. Here are some of those answers.

Research suggests cannabis suppresses REM sleep, raising questions about memory, emotion and the purpose of dreams.

Jazz Pharmaceuticals JAZZ is best known for its market-leading oxybate franchise, but the company has also carved out a unique position in cannabinoid-based medicine. It markets Epidiolex, the first ...

In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.

Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses ...

The adult epilepsy market across the 7MM is poised to grow at a CAGR of 4.4% from $11.4bn in 2025 to $17.8bn in 2035.

Former acting DHS Secretary Chad Wolf urges Congress to investigate Chinese-linked actors' role in THC hemp products and illegal marijuana operations.

In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a ...

Texas will ban delta-8, delta-10, THCP and other hemp products July 31. Here's what remains legal after the Supreme Court ...